UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors

Pancreas, 2020-08, Vol.49 (7), p.863-881

2020

Volltextzugriff (PDF)

NANETS consensus guidelines for the diagnosis of neuroendocrine tumor

Pancreas, 2010-08, Vol.39 (6), p.713-734

2010

Volltextzugriff (PDF)

The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum

Pancreas, 2010-08, Vol.39 (6), p.767-774

2010

Volltextzugriff (PDF)

The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors

Pancreas, 2017-07, Vol.46 (6), p.707-714

2017

Volltextzugriff (PDF)

Development of a highly sensitive and specific carboxy-terminal human pancreastatin assay to monitor neuroendocrine tumor behavior

Pancreas, 2010-07, Vol.39 (5), p.611-616

2010

Volltextzugriff (PDF)

Neuroendocrine tumors: a critical appraisal of management strategies

Pancreas, 2010-08, Vol.39 (6), p.801-818

2010

Volltextzugriff (PDF)

Radioligand Theranostics in the Management of Neuroendocrine Tumors

Pancreas, 2020-05, Vol.49 (5), p.599-603

2020

Volltextzugriff (PDF)

A single fasting plasma 5-HIAA value correlates with 24-hour urinary 5-HIAA values and other biomarkers in midgut neuroendocrine tumors (NETs)

Pancreas, 2013-04, Vol.42 (3), p.405-410

2013

Volltextzugriff (PDF)

Peptide Receptor Radionuclide Therapy Outcomes in a North American Cohort With Metastatic Well-Differentiated Neuroendocrine Tumors

Pancreas, 2017-02, Vol.46 (2), p.151-156

2017

Volltextzugriff (PDF)

Clinical value of monitoring plasma octreotide levels during chronic octreotide long-acting repeatable therapy in carcinoid patients

Pancreas, 2008-07, Vol.37 (1), p.94-100

2008

Volltextzugriff (PDF)

Management of Diarrhea in Patients With Carcinoid Syndrome

Pancreas, 2019-09, Vol.48 (8), p.961-972

2019

Volltextzugriff (PDF)

Comparison of transarterial liver-directed therapies for low-grade metastatic neuroendocrine tumors in a single institution

Pancreas, 2014-03, Vol.43 (2), p.219-225

2014

Volltextzugriff (PDF)

Validation of neurokinin a assays in the United States and Europe

Pancreas, 2011-10, Vol.40 (7), p.1000-1005

2011

Volltextzugriff (PDF)

A prospective trial on the effect of body mass index and sex on plasma octreotide levels in patients undergoing long-term octreotide LAR therapy

Pancreas, 2010-10, Vol.39 (7), p.964-966

2010

Volltextzugriff (PDF)

Elevated pancreatic polypeptide levels in pancreatic neuroendocrine tumors and diabetes mellitus: causation or association?

Pancreas, 2014-05, Vol.43 (4), p.651-656

2014

Volltextzugriff (PDF)

Prospective Analysis of the Impact of 68Ga-DOTATOC Positron Emission Tomography–Computerized Axial Tomography on Management of Pancreatic and Small Bowel Neuroendocrine Tumors

Pancreas, 2020-09, Vol.49 (8), p.1033-1036

2020

Volltextzugriff (PDF)

Repeatability of gallium-68 DOTATOC positron emission tomographic imaging in neuroendocrine tumors

Pancreas, 2013-08, Vol.42 (6), p.937-943

2013

Volltextzugriff (PDF)

Validation of serum versus plasma measurements of chromogranin a levels in patients with carcinoid tumors: lack of correlation between absolute chromogranin a levels and symptom frequency

Pancreas, 2006-10, Vol.33 (3), p.250-254

2006

Volltextzugriff (PDF)

Effect of octreotide LAR dose and weight on octreotide blood levels in patients with neuroendocrine tumors

Pancreas, 2005-11, Vol.31 (4), p.392-400

2005

Volltextzugriff (PDF)

Gastric electrical stimulation is associated with improvement in pancreatic exocrine function in humans

Pancreas, 2004-08, Vol.29 (2), p.e41-e44

2004

Volltextzugriff (PDF)

Peptide receptor radionuclide therapy with 177Lu-DOTATATE for patients with somatostatin receptor-expressing neuroendocrine tumors: the first US phase 2 experience

Pancreas, 2014-05, Vol.43 (4), p.518-525

2014

Volltextzugriff (PDF)

The Utility of F-18 DOPA PET/CT in Identifying Unknown Site of Primary Neuroendocrine Disease

Pancreas, 2010-03, Vol.39 (2), p.281

2010

Volltextzugriff (PDF)

The North American Neuroendocrine Tumor Society (NANETS) guidelines: mission, goals, and process

Pancreas, 2010-08, Vol.39 (6), p.705-706

2010

Volltextzugriff (PDF)

Risk Factors for Sporadic Pancreatic Neuroendocrine Tumors (PNETs): A Single-Center Case Control Study

Pancreas, 2010-03, Vol.39 (2), p.279

2010

Volltextzugriff (PDF)

Discordant Expression of Proliferating Cell Nuclear Antigen (PCNA) and Ki-67 Antigen in Carcinoid and Pancreatic Neuroendocrine Tumors (C&PET) Likely Indicates Enhanced DNA Repair

Pancreas, 2010-03, Vol.39 (2), p.274

2010

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SeriePancreas

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)

Publikationsform

Artikel
(34)

Sprache

Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Gastroenterology & Hepatology
(20)
Humans
(20)
Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Female
(10)
Male
(10)
Neuroendocrine Tumors
(10)
Middle Aged
(8)
Adult
(7)
Aged
(7)
Neuroendocrine Tumors - Diagnosis
(6)
Neuroendocrine Tumors - Therapy
(5)
Treatment Outcome
(5)
Biomarkers, Tumor - Blood
(4)
Carcinoid
(4)
Carcinoid Syndrome
(4)
Kaplan-Meier Estimate
(4)
Neuroendocrine Tumors - Blood
(4)
Neuroendocrine Tumors - Drug Therapy
(4)
Neuroendocrine Tumors - Radiotherapy
(4)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Journals@Ovid Ovid Full Text
(34)
MEDLINE
(20)

Menü

Weitere Dienste

Einstellungen

The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors

NANETS consensus guidelines for the diagnosis of neuroendocrine tumor

The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum

The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors

Development of a highly sensitive and specific carboxy-terminal human pancreastatin assay to monitor neuroendocrine tumor behavior

Neuroendocrine tumors: a critical appraisal of management strategies

Radioligand Theranostics in the Management of Neuroendocrine Tumors

A single fasting plasma 5-HIAA value correlates with 24-hour urinary 5-HIAA values and other biomarkers in midgut neuroendocrine tumors (NETs)

Peptide Receptor Radionuclide Therapy Outcomes in a North American Cohort With Metastatic Well-Differentiated Neuroendocrine Tumors

Clinical value of monitoring plasma octreotide levels during chronic octreotide long-acting repeatable therapy in carcinoid patients

Management of Diarrhea in Patients With Carcinoid Syndrome

Comparison of transarterial liver-directed therapies for low-grade metastatic neuroendocrine tumors in a single institution

Validation of neurokinin a assays in the United States and Europe

A prospective trial on the effect of body mass index and sex on plasma octreotide levels in patients undergoing long-term octreotide LAR therapy

Elevated pancreatic polypeptide levels in pancreatic neuroendocrine tumors and diabetes mellitus: causation or association?

Prospective Analysis of the Impact of 68Ga-DOTATOC Positron Emission Tomography–Computerized Axial Tomography on Management of Pancreatic and Small Bowel Neuroendocrine Tumors

Repeatability of gallium-68 DOTATOC positron emission tomographic imaging in neuroendocrine tumors

Validation of serum versus plasma measurements of chromogranin a levels in patients with carcinoid tumors: lack of correlation between absolute chromogranin a levels and symptom frequency

Effect of octreotide LAR dose and weight on octreotide blood levels in patients with neuroendocrine tumors

Gastric electrical stimulation is associated with improvement in pancreatic exocrine function in humans

Peptide receptor radionuclide therapy with 177Lu-DOTATATE for patients with somatostatin receptor-expressing neuroendocrine tumors: the first US phase 2 experience

The Utility of F-18 DOPA PET/CT in Identifying Unknown Site of Primary Neuroendocrine Disease

The North American Neuroendocrine Tumor Society (NANETS) guidelines: mission, goals, and process

Risk Factors for Sporadic Pancreatic Neuroendocrine Tumors (PNETs): A Single-Center Case Control Study

Discordant Expression of Proliferating Cell Nuclear Antigen (PCNA) and Ki-67 Antigen in Carcinoid and Pancreatic Neuroendocrine Tumors (C&PET) Likely Indicates Enhanced DNA Repair

Aktive Filter

Suchergebnisse filtern